Discontinuation report ACTONEL
Report ID | 67753 |
Drug Identification Number | 02239146 |
Brand name | ACTONEL |
Common or Proper name | ACTONEL 30MG TAB 30 CA |
Company Name | ALLERGAN PHARMA CO. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 30MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30MG TAB 30 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-01-20 |
Remaining supply date | 2017-01-20 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinuation of 30mg based on requirement to transfer manufacturing site. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-11-28 | French | Compare |
v1 | 2018-11-28 | English | Compare |
Showing 1 to 2 of 2